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Abstract 
This study investigated strategies for ascertaining preeclampsia, pregnancy hypertension 
and gestational diabetes mellitus from birth records and/or hospital discharge data.  The 
results showed that ascertaining these conditions from a dataset that linked birth records 
to the corresponding maternal hospital record for birth was sufficient for health outcomes 
research.  Antenatal hospital records provided few extra cases and may be necessary only 
for the ascertainment when a very accurate estimate of the prevalence is required. 
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Introduction 
Pregnancy hypertension (including gestational hypertension, preeclampsia and 
eclampsia) and gestational diabetes mellitus (GDM) are common complications during 
pregnancy and have adverse consequences for both mothers and babies, including for 
hypertensive disorders: preterm birth, growth restricted infants, perinatal death, obstetric 
haemorrhage, acute renal or hepatic failure and maternal death; and for GDM: 
preeclampsia, macrosomic infants, induction of labour and caesarean delivery.1-5  
Accurate ascertainment of these conditions is important for maternity care service 
planning and health outcomes research.  
 
Population health data such as hospital discharge and birth records have been used in 
studies of pregnancy hypertension and GDM.2;6-8  However, these data are not primarily 
collected for research.  Concerns about the completeness of disease ascertainment in 
either dataset have been raised as a limitation of using single datasets for research.9-12  
Linking birth records to the corresponding birth admission hospital records (one to one 
linkage) has been used to improve ascertainment.7  As only diagnoses affecting the birth 
admission are required to be coded in hospital discharge data, a more complex linkage 
adding information from antenatal hospital records is likely to further improve 
identification of the conditions.13  This study assessed the impact of different methods of 
ascertaining preeclampsia, pregnancy hypertension and GDM in population health data 
on the prevalence of these conditions and the statistical modelling of selected pregnancy 
outcomes.  
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Methods 
Study population and data sources  
The study population included 185,416 women who gave birth in NSW hospitals during 
2007-2008 and had both a birth record in NSW Midwives Data Collection (‘birth data’) 
and a birth admission record in hospital data.  Birth data include information on all live 
births or stillbirths of at least 20 weeks gestation or at least 400 grams birth weight in 
NSW.  The collected information includes number of previous births, pregnancy 
complications (including preeclampsia, gestational pregnancy hypertension and GDM), 
pregnancy, labour, delivery and perinatal outcomes.  The NSW Admitted Patient Data 
Collection (‘hospital data’) covers every inpatient admission in NSW, and includes 
demographic information and episode-related data which are coded according to the tenth 
revision of the International Classification of Diseases Australian Modification (ICD-10-
AM).14  Record linkage of the birth and hospital data (by the Centre for Health Record 
Linkage15) was approved by the NSW Population and Health Services Research Ethics 
Committee.  As this study conforms to the standards established by the NHMRC for 
ethical quality review,16 ethics approval was not sought. 
 
Disease ascertainment 
Preeclampsia, pregnancy hypertension or GDM can be identified from birth data and/or 
hospital data with very high specificities (i.e. >99%) indicating few false positives.11;12  
In the birth data preeclampsia, gestational hypertension or GDM were determined if 
‘Yes’ was recorded in response to the relevant question in the birth record.  In hospital 
data, any record with a diagnosis of gestational hypertension (ICD10-AM: O13 and O16), 
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preeclampsia (O11 and O14) or eclampsia (O15); and diabetes mellitus arising during 
pregnancy (O24.4) was included.  
 
We compared five different methods of ascertaining disease rates from population data, 
from: (1) birth record alone, (2) birth admission hospital record alone, (3) either the birth 
record or birth admission hospital record (4) antenatal hospitalisation record, and (5) any 
record – birth, birth admission or antenatal hospitalisation. 
 
Outcomes for statistical modeling of these conditions included small for gestational age 
(SGA)17 (i.e. ≤10th percentile of birth weight for gestational age), large for gestational age 
(LGA) (i.e. ≥90th percentile of birth weight for gestational age), preterm birth (<37 
weeks), caesarean section (CS) and induction.   
 
Data analysis 
Using the different ascertainment methods, the proportion of women with preeclampsia, 
pregnancy hypertension or GDM was calculated and logistic regression was used to 
determine the effect size (odds ratio) on the selected outcomes.  The capacity of a model 
to predict an outcome was evaluated using the area under the receiver-operating 
characteristic (ROC) curve (C-statistic), with values of 1.0 representing perfect 
discrimination and 0.5 indicating no better than chance.  Data were analysed separately 
for women with and without a previous birth. 
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Results 
Of the 185,416 study subjects, 41.5% (n=76,898) were women having their first birth and 
25.2% (n=46,753) had been hospitalised during pregnancy (other than the birth 
admission)(Table 1).  These 46,753 women had a total of 75,944 antenatal hospital 
admissions with a median of one antenatal admission per pregnancy (range: 1 to 39).   
 
The prevalence of preeclampsia, pregnancy hypertension and GDM based on all available 
data was 3.4%, 9.7% and 6.0% respectively for all women.  The number and frequency of 
these conditions varied by the different ascertainment methods and by parity (Table 2).  
The number of cases ascertained and associated prevalence estimates for all three 
conditions were higher in the birth admission hospital records than in birth data.  The 
prevalence estimates increased significantly when birth admission and birth records were 
combined, and the proportional increase from using birth admission hospital records 
alone ranged from 12% for GDM at first pregnancy to 50% for pregnancy hypertension at 
second and subsequent pregnancies.  However, the additional (case) ascertainment from 
including antenatal hospital records was small and the largest relative increase from using 
combined birth admission and birth records was only 8% for preeclampsia at second and 
subsequent pregnancies, representing an absolute increase from 2.1% to 2.2%.   
 
Case ascertainment based on a single data source (birth admission hospital records or 
birth records) gave effect sizes for SGA, LGA, preterm birth, CS and induction that could 
be quite different (Table 2).  For example, the odds ratio for the effect of preeclampsia on 
induction in a first pregnancy was 2.84 (95% confidence intervals (CI): 2.63-3.06) and 
4.24 (95% CI: 3.88-4.63) for cases ascertained from birth admission hospital records or 
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birth records respectively, whereas the odds ratio for the effect of preeclampsia on 
cesarean section at second and subsequent pregnancies was 2.66 (95% CI: 2.42-2.93) and 
2.12 (95% CI: 1.89-2.38) respectively.  In contrast, case ascertainment from combined 
birth admission and birth records or from all available data did not change the effect sizes 
of any condition for any of the outcomes, with the largest relative change being less than 
5% (i.e. odds ratio for the effect of preeclampsia on preterm birth at second and 
subsequent pregnancies: from 5.24 to 5.55).  The inclusion of additional cases from 
antenatal hospital records resulted in little difference in the predictive capacities of 
models for any outcome when compared to models using information collected at the 
time of birth.  For example, for preeclampsia ascertained from combined birth admission 
and birth records compared to all data, the C-statistics for the prediction of preterm birth 
at first birth were 0.5670 and 0.5692 respectively; this represented the largest difference 
between the two C-statistics for all the analyses.   
 
Discussion 
This study showed that simply linking birth records to the corresponding birth admission 
hospital records can significantly improve the ascertainment of preeclampsia, pregnancy 
hypertension and GDM, but additional linkage to antenatal hospital records did little to 
further the improvement.  A validation study of 4541 women in Washington, USA, using 
information in medical records as the ‘gold standard’, reported that hospital discharge 
and birth records combined gave higher sensitivity for pregnancy hypertension and GDM 
(74% and 93% respectively) than did either hospital discharge (71% and 81% 
respectively) or birth records (49% and 64% respectively) alone.18  This was also the case 
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in a random sample of 1184 NSW women who gave birth in 20029;11;  the sensitivity in 
birth data, hospital data and the two data combined were 63%, 68% and 82% respectively 
for pregnancy hypertension and 63%, 69% and 73% respectively for GDM.  These results 
support the rationale of combining hospital data and birth data for ascertaining these 
conditions. 
 
Although antenatal hospital records provided additional cases, the relative increase in the 
number of total cases in this study was small (less than 8% relative increase) and did not 
affect the estimate of the odds ratio of preeclampsia, pregnancy hypertension or GDM 
and the predictive capacity of any model.  We previously reported that additional 
information on chronic diseases, such as preexisting hypertension and cardiac disease, 
from hospital admissions prior to pregnancy (lookback up to five years) did little to 
improve the modelling of risk factors for obstetric haemorrhage.19  The data manipulation 
required for identifying prior admissions is challenging, requiring multiple steps of data 
merging and development of the decision rules for resolving conflicting information from 
different records, but the additional effort may have little or no impact on the study 
results.  This is reassuring for settings where antenatal data are not available, or 
individuals’ records are not identifiable.   
 
In general, the odds ratios for pregnancy outcomes (Table 2) based on exposure 
information obtained from either birth or hospital data were lower than those obtained 
from hospital data alone (the more reliable source).  This likely reflects that the increased 
ascertainment achieved using more than one data source provides a more accurate 
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distribution (with respect to severity) of disease in the population. Validation studies have 
repeatedly shown that identifying conditions from more than one data source increases 
accurate ascertainment, with higher sensitivity of reporting but without increasing the 
false positive reports.9,11,18  In addition, in any single data source, more severe disease or 
disease associated with adverse outcome is more likely to be reported.21,22  The 
combination of these facts suggests that using more than one data source would increase 
the proportion of women with mild disease, consistent with the lower odds ratios 
obtained. 
 
In this study, pregnancy hypertension was estimated to be around 9.7%; this prevalence is 
similar to the estimate of 8.3% from the audit of medical records of 1184 randomly 
selected women in NSW in 2002.11  The prevalence of 6.0% for GDM in this study is 
higher than the NSW medical record audit (4.8%)9 but consistent with increased GDM 
screening.20  For maternity care service planning, it is important to have accurate 
estimation of the proportion of women who are affected by these conditions as a small 
improvement in the ascertainment rate may translate into a large number of women at the 
population level and the resources required for caring for these women could be 
substantial.     
 
In conclusion, whenever it is feasible, combined birth admission and birth records should 
be used to identify pregnancy hypertension and GDM.  The resulting ascertainment rate 
is sufficient for health outcomes research.  For assessing the burden of these conditions, 
additional information from the antenatal hospital records should be considered.  
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Table 1. Number of women with antenatal period hospital records, New South Wales, 2007-2008 
 1st pregnancy 
N=76,898† 
N (%) 
≥2nd pregnancy 
N=108,518† 
N (%) 
Total 
N=185,416† 
N (%) 
Women with any antenatal hospital record 21,358 (27.8)‡ 25,395 (23.4)‡ 46,753 (25.2) ‡ 
Number of antenatal hospital record/s    
    1 13,374 (62.6) 16,577 (65.3) 29,951 (64.1) 
    2 5,101 (23.9) 5,315 (20.9) 10,416 (22.3) 
    3 1,704 (8.0) 1,942 (7.6) 3,646 (7.8) 
    4 625 (2.9) 798 (3.1) 1,423 (3.0) 
    ≥5 554 (2.6) 763 (3.0) 1,317 (2.8) 
    Total  21,358 (100) 25,395 (100) 46,753 (100) 
† Number of women with linked birth and birth admission hospital records 
‡ Number and percentage of women who were hospitalised during the pregnancy, other than the birth admission. 
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Table 2. Prevalence of preeclampsia, pregnancy hypertension and gestational diabetes and odds ratio (OR) of these conditions for various 
maternal and neonatal outcomes by different methods of ascertainment, New South Wales, 2007-2008 
 1st pregnancy 
 
N=76,898 
N (%) 
SGA† or 
LGA‡ 
OR  
(95% CI) 
Preterm Birth 
OR  
(95% CI) 
Caesarean 
Section  
OR  
(95% CI) 
Induction 
 
OR  
(95% CI) 
≥2nd pregnancy 
 
N=108,518 
N (%) 
SGA† or 
LGA‡ 
OR  
(95% CI) 
Preterm 
Birth 
OR  
(95% CI) 
Caesarean 
Section  
OR  
(95% CI) 
Induction 
 
OR  
(95% CI) 
Preeclampsia           
    Birth record 2187 (2.8%) 1.39†  
(1.24-1.55) 
5.83  
(5.29-6.42) 
2.37  
(2.17-2.58) 
4.24  
(3.88-4.63) 
1172 (1.1%) 2.03†  
(1.73-2.39) 
5.91  
(5.18-6.73) 
2.12  
(1.89-2.38) 
3.96  
(3.53-4.45) 
    Birth admission hospital  
record  
2854 (3.7%) 1.55†  
(1.40-1.71) 
6.44 
(5.91-7.01) 
3.09  
(2.87-3.33) 
2.84  
(2.63-3.06) 
1712 (1.6%) 2.20†  
(1.93-2.51) 
6.78  
(6.10-7.54) 
2.66  
(2.42-2.93) 
2.69  
(2.44-2.97) 
    Birth record + birth 
admission hospital record 
3687 (4.8%) 1.44† 
(1.31-1.57) 
5.24 
(4.84-5.67) 
2.63  
(2.46-2.82) 
3.47  
(3.24-3.71) 
2255 (2.1%) 2.00†  
(1.77-2.24) 
5.55  
(5.03-6.12) 
2.30  
(2.11-2.50) 
3.08  
(2.83-3.35) 
    Antenatal hospital 
record/s  
780 (1.0%) 1.34 
(1.11-1.62) 
8.12 
(7.01-9.41) 
3.35  
(2.90-3.87) 
2.06  
(1.79-2.37) 
501 (0.5%) 2.15 
(1.69-2.73) 
7.31 
(6.05-8.82) 
2.78  
(2.33-3.31) 
2.76  
(2.31-3.30) 
    Birth record + all hospital 
records 
3919 (5.1%) 1.43†  
(1.31-1.56) 
5.13  
(4.74-5.54) 
2.61  
(2.45-2.79) 
3.35  
(3.14-3.58) 
2430 (2.2%) 1.98†  
(1.77-2.22) 
5.30  
(4.82-5.83) 
2.27  
(2.09-2.46) 
3.07  
(2.83-3.33) 
Pregnancy hypertension           
    Birth record 6,215 (8.1%) 1.12†  
(1.04-1.20) 
2.58  
(2.40-2.78) 
1.80  
(1.70-1.89) 
3.24  
(3.08-3.42) 
5,171 (4.8%) 1.13†  
(1.03-1.24) 
2.09  
(1.91-2.28) 
1.45  
(1.37-1.54) 
2.84  
(2.68-3.01) 
    Birth admission hospital  
record  
7,226 (9.4%) 1.35† 
(1.26-1.44) 
2.89 
(2.70-3.10) 
2.15  
(2.05-2.26) 
3.30  
(3.15-3.47) 
5,211 (4.8%) 1.55†  
(1.43-1.70) 
2.91  
(2.69-3.15) 
1.62  
(1.53-1.71) 
3.12  
(2.95-3.30) 
    Birth record + birth 
admission hospital record 
9,178 (11.9%) 1.22† 
 (1.15-1.30) 
2.44 
(2.29-2.61) 
2.00  
(1.91-2.09) 
2.70  
(2.59-2.83) 
7,809 (7.2%) 1.23†  
(1.13-1.32) 
2.24  
(2.08-2.40) 
1.59  
(1.52-1.67) 
2.49  
(2.38-2.61) 
    Antenatal hospital 
record/s  
2,696 (3.5%) 1.23 
(1.10-1.37) 
3.32 
(3.01-3.67) 
2.06  
(1.91-2.23) 
2.40  
(2.22-2.59) 
2033 (1.9%) 1.56 
(1.36-1.78) 
3.26 
(2.90-3.66) 
1.96  
(1.79-2.14) 
2.27  
(2.08-2.49) 
    Birth record + all hospital 
records 
9,718 (12.6%) 1.20†  
(1.13-1.27) 
2.38 
(2.23-2.54) 
1.95  
(1.87-2.04) 
2.58  
(2.47-2.70) 
8,335 (7.7%) 1.20†  
(1.12-1.30) 
2.18  
(2.03-2.34) 
1.61  
(1.54-1.69) 
2.39  
(2.28-2.50) 
Gestational diabetes           
    Birth record 3,420 (4.4%) 1.09‡  
(0.96-1.24) 
1.19  
(1.05-1.34) 
1.44  
(1.34-1.54) 
2.40  
(2.24-2.57) 
5,029 (4.6%) 1.38‡  
(1.28-1.50) 
1.29  
(1.16-1.44) 
1.41  
(1.33-1.50) 
2.23  
(2.11-2.37) 
    Birth admission hospital  
record  
3,860 (5.0%) 1.04‡  
(0.92-1.18) 
1.30 
(1.16-1.46) 
1.56  
(1.46-1.67) 
2.11 
(1.98-2.25) 
5754 (5.3%) 1.38‡ 
(1.28-1.48) 
1.44  
(1.31-1.59) 
1.52  
(1.43-1.60) 
1.97  
(1.86-2.09) 
    Birth record + birth 
admission hospital record 
4,339 (5.6%) 1.04‡ 
(0.93-1.17) 
1.33 
(1.20-1.48) 
1.50  
(1.40-1.59) 
1.98  
(1.86-2.10) 
6,633 (6.1%) 1.34‡  
(1.25-1.44) 
1.37  
(1.25-1.50) 
1.50  
(1.42-1.58) 
1.81  
(1.72-1.91) 
    Antenatal hospital 
record/s  
580 (0.8%) 1.39 
(1.05-1.82) 
2.19 
(1.74-2.77) 
1.85  
(1.57-2.18) 
1.95  
(1.66-2.30) 
948 (0.9%) 1.72 
(1.46-2.02)) 
3.42 
(2.90-4.04) 
1.94  
(1.71-2.21) 
2.02  
(1.77-2.31) 
    Birth record + all hospital 
records 
4,359 (5.7%) 1.04‡  
(0.93-1.17) 
1.34 
(1.21-1.49) 
1.50  
(1.41-1.60) 
1.96  
(1.85-2.09) 
6,705 (6.2%) 1.33‡  
(1.24-1.43) 
1.39  
(1.27-1.52) 
1.51  
(1.43-1.59) 
1.80  
(1.71-1.90) 
† SGA - Small for gestational age is the only independent variable in the analysis ‡ SGA - Large for gestational age is the only independent variable in the analysis  
